Endometrial cancer is the most common gynecologic malignancy in developed countries. Clear cell carcinoma typically occurs in the ovaries, and very rarely occurs in the endometrium; it accounts for less than 3% of all endometrial cancers. It is presumed that clear cell carcinomas are of Müllerian duct origin, and an association with exposure to diethylstilbestrol (DES) or other nonsteroidal follicle stimulating hormones has been described. We report a case of a postmenopausal woman who presented with vaginal bleeding without a specific medical history. Under the impression of an endometrial mass, we performed a laparoscopic operation. Pathologic results showed clear cell carcinoma of the endometrium. Depth of invasion was 0.2 cm out of a 0.5 cm total thickness, and the rectal shelf mass was clear cell carcinoma. We report the case with a brief review of the relevant literature. (J Menopausal Med 2016;22:122-125)
Introduction
Endometrial cancer is the most common gynecologic malignancy in developed countries, and its incidence has more than doubled over the last 10 years in Korea. 1 Clear cell carcinoma typically occurs in the ovaries, is rarely seen in the cervix or vagina, and very rarely occurs in the endometrium, accounting for less than 3% of all endometrial cancers. 2 The addition of radiation therapy is not the exact protocol, and its definite roles still remain controversial. This is because that this therapy is used infrequently and radiation doses and methods vary according to institutions. A recent study on the addition of chemotherapy addressed that the addition of radiation therapy had no influence on survival rate and chemotherapy was more effective. 
